Nabil Amirouchene-Angelozzi

Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth

Giovanni Germano, Simona Lamba, Giuseppe Rospo et al. · Nature · 2017 · 608 citations

Chromatin, Genome Instability, Dna Damage +12

Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target

Nabil Amirouchene-Angelozzi, Fariba Némati, David Gentien et al. · Molecular Oncology · 2014 · 169 citations · Full text

Evolving neoantigen profiles in colorectal cancers with DNA repair defects

Giuseppe Rospo, Annalisa Lorenzato, Nabil Amirouchene-Angelozzi et al. · Genome Medicine · 2019 · 61 citations · Full text

The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma

Nabil Amirouchene-Angelozzi, Estelle Frisch-Dit-Leitz, Guillaume Carita et al. · Oncotarget · 2016 · 44 citations · Full text

Chemoprevention Strategy, Pi3k Inhibitor Gdc0941, Dermatology +16

Pembrolizumab in MMR-proficient metastatic colorectal cancer pharmacologically primed to trigger dynamic hypermutation status: The ARETHUSA trial.

Salvatore Siena, Andrea Sartore‐Bianchi, Nicola Personeni et al. · Journal of Clinical Oncology · 2019 · 14 citations

Immunology, Pathology, Immunotherapeutics +21